JP2009535419A - 便秘型過敏性腸症候群の治療方法 - Google Patents

便秘型過敏性腸症候群の治療方法

Info

Publication number
JP2009535419A
JP2009535419A JP2009509989A JP2009509989A JP2009535419A JP 2009535419 A JP2009535419 A JP 2009535419A JP 2009509989 A JP2009509989 A JP 2009509989A JP 2009509989 A JP2009509989 A JP 2009509989A JP 2009535419 A JP2009535419 A JP 2009535419A
Authority
JP
Japan
Prior art keywords
ibs
day
crofelemer
composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009509989A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009535419A5 (https=
Inventor
バリー クォート
デイビット ローゼンバウム
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Napo Pharmaceuticals Inc
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of JP2009535419A publication Critical patent/JP2009535419A/ja
Publication of JP2009535419A5 publication Critical patent/JP2009535419A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2009509989A 2006-05-01 2007-04-30 便秘型過敏性腸症候群の治療方法 Pending JP2009535419A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79707606P 2006-05-01 2006-05-01
PCT/US2007/067739 WO2007130892A2 (en) 2006-05-01 2007-04-30 Method for treatment of constipation-predominant irritable bowel syndrome

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013246845A Division JP2014058548A (ja) 2006-05-01 2013-11-29 便秘型過敏性腸症候群の治療方法

Publications (2)

Publication Number Publication Date
JP2009535419A true JP2009535419A (ja) 2009-10-01
JP2009535419A5 JP2009535419A5 (https=) 2010-06-17

Family

ID=38668465

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009509989A Pending JP2009535419A (ja) 2006-05-01 2007-04-30 便秘型過敏性腸症候群の治療方法
JP2013246845A Pending JP2014058548A (ja) 2006-05-01 2013-11-29 便秘型過敏性腸症候群の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013246845A Pending JP2014058548A (ja) 2006-05-01 2013-11-29 便秘型過敏性腸症候群の治療方法

Country Status (18)

Country Link
US (3) US7556831B2 (https=)
EP (2) EP2015639A4 (https=)
JP (2) JP2009535419A (https=)
KR (2) KR20130067317A (https=)
AU (1) AU2007248182B2 (https=)
CA (1) CA2650022C (https=)
CY (1) CY1113723T1 (https=)
DK (1) DK2241318T3 (https=)
ES (1) ES2401366T3 (https=)
HR (1) HRP20130203T1 (https=)
MX (1) MX2008013768A (https=)
NZ (3) NZ609280A (https=)
PL (1) PL2241318T3 (https=)
PT (1) PT2241318E (https=)
RS (1) RS52678B (https=)
SG (2) SG195538A1 (https=)
SI (1) SI2241318T1 (https=)
WO (1) WO2007130892A2 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009535417A (ja) * 2006-05-01 2009-10-01 ナポ ファーマシューティカルズ インク． 下痢型過敏性腸症候群の治療方法
JP2010154769A (ja) * 2008-12-26 2010-07-15 Asahi Breweries Ltd ポリフェノール含有顆粒またはポリフェノール含有チュアブル錠剤およびその製造方法
JP2013540826A (ja) * 2010-10-31 2013-11-07 サリックス ファーマシューティカルズ リミテッド Ｈｉｖ関連の下痢を治療するための方法および組成物

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
SI2241318T1 (sl) 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8734867B2 (en) 2007-12-28 2014-05-27 Liveleaf, Inc. Antibacterial having an extract of pomegranate combined with hydrogen peroxide
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
WO2009131957A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising oxadiazole derivatives
US20090264433A1 (en) * 2008-04-21 2009-10-22 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Triazine Derivatives
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
RU2571924C2 (ru) 2009-03-04 2015-12-27 ЛайвЛиф, Инк., Способ и вещество для активируемого сайтом комплексообразования биологических молекул
US8511216B2 (en) * 2009-03-30 2013-08-20 Kanzaki Kokyukoki Mfg. Co., Ltd. Hydraulic actuator unit
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US9192635B2 (en) 2011-06-24 2015-11-24 Liveleaf, Inc. Method of treating damaged mucosal or gastrointestinal tissue by administering a composition comprising a mixture of pomegranate and green tea extracts and releasably bound hydrogen peroxide
US20120329736A1 (en) * 2011-06-24 2012-12-27 Huang Alexander L Treatment for gastrointestinal disorders using a selective, site-activated binding system
US8722040B2 (en) 2011-06-24 2014-05-13 Liveleaf, Inc. Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites
CN104902911A (zh) 2012-11-21 2015-09-09 Kbs研究有限公司 草药补充剂及其使用方法
US8716351B1 (en) 2012-12-23 2014-05-06 Liveleaf, Inc. Methods of treating gastrointestinal spasms
US9510880B2 (en) 2013-08-13 2016-12-06 Zimmer, Inc. Polyaxial locking mechanism
WO2015184109A1 (en) * 2014-05-29 2015-12-03 Jaguar Animal Health, Inc. Methods of treating diarrhea in adult non-human animals
US10282369B2 (en) * 2017-03-08 2019-05-07 Centri Technology, Inc. Fast indexing and searching of encoded documents
US11857510B2 (en) 2017-05-31 2024-01-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating congenital diarrhea disorder
JP7328153B2 (ja) 2017-05-31 2023-08-16 ナポ ファーマシューティカルズ インク． 胆汁酸性下痢、小腸切除又は胆嚢除去及び短腸症候群に関連する下痢を治療するための方法及び組成物
WO2019014714A1 (en) * 2017-07-17 2019-01-24 smartDNA Pty Ltd DIAGNOSTIC METHOD OF DYSBIOSIS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
JP2001524938A (ja) * 1996-10-16 2001-12-04 シャーマン ファーマシューティカルズ，インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE446940B (sv) 1983-02-16 1986-10-20 Carl Axel Virdalm Medel for bekempande av sjukdomstillstand i matsmeltningsapparaten innehallande skal eller ytterdelar av ber eller frukter
US4698360B1 (en) 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
DE3564370D1 (en) 1985-08-30 1988-09-22 Nestle Sa Dietetic product with depurating and antidiarrheal activity and process for its preparation
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
SI9011933A (sl) 1990-10-15 1998-06-30 TANIN SEVNICA Kemična industrija p.o. Kostanjev taninski ekstrakt, postopek za njegovo pridobivanje in njegova uporaba
US5234922A (en) 1992-09-28 1993-08-10 University Of Iowa Research Foundation Use of sulfonylureas and other potassium channel regulators to treat secretory diarrhea
US6281240B1 (en) 1997-04-10 2001-08-28 Eli Lilly And Company Diarylsulfonylureas for use in treating secretory diarrhea
CN1215561A (zh) * 1997-10-27 1999-05-05 邢文海 保健茶
US7767203B2 (en) * 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
CN1159054C (zh) 2002-01-22 2004-07-28 随志化 通腑止泻剂
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
US20040063695A1 (en) 2002-09-30 2004-04-01 Alan Verkman Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
US7208183B2 (en) 2002-10-05 2007-04-24 Bobrowski Paul J Methods and preparations of the latex from the croton species
US7303772B2 (en) * 2005-11-10 2007-12-04 Olalde Rangel Jose Angel Synergistic phytoceutical compositions
ES2616012T3 (es) 2006-05-01 2017-06-09 Napo Pharmaceuticals, Inc. Composiciones para tratar o prevenir enfermedad inflamatoria del intestino
SI2241318T1 (sl) 2006-05-01 2013-04-30 Napo Pharmaceuticals, Inc. Postopek za zdravljenje sindroma iritabilnega ÄŤrevesa s predominantno obstipacijo
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
AU2010303577B2 (en) 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
CN107595836A (zh) 2010-10-31 2018-01-19 纳珀制药公司 用于治疗hiv相关性腹泻的方法和组合物
EP2928560A4 (en) 2012-12-07 2016-06-01 Salix Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001524938A (ja) * 1996-10-16 2001-12-04 シャーマン ファーマシューティカルズ，インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012042681; ＤＩＣＥＳＡＲＥ，Ｄ．　ｅｔ　ａｌ: 'Ａ　ｄｏｕｂｌｅ　ｂｌｉｎｄ，　ｒａｎｄｏｍｉｚｅｄ，　ｐｌａｃｅｂｏ-ｃｏｎｔｒｏｌｌｅｄ　ｓｔｕｄｙ　ｏｆ　ＳＰ-３０３　（Ｐｒｏｖｉｒ）　ｉｎ　ｔｈｅ　ｓｙｍｐｔｏｍａｔｉｃ　ｔｒｅａｔｍｅｎｔ' Ａｍ　Ｊ　Ｇａｓｔｒｏｅｎｔｅｒｏｌ Ｖｏｌ．９７，　Ｎｏ．１０, 2002, ｐｐ．２５８５-２５８８ *
JPN6012042682; ＦＩＳＣＨＥＲ，Ｈ．　ｅｔ　ａｌ: 'Ａ　ｎｏｖｅｌ　ｅｘｔｒａｃｔ　ＳＢ-３００　ｆｒｏｍ　ｔｈｅ　ｓｔｅｍ　ｂａｒｋ　ｌａｔｅｘ　ｏｆ　Ｃｒｏｔｏｎ　ｌｅｃｈｌｅｒｉ　ｉｎｈｉｂｉｔｓ　ＣＦＴＲ-ｍｅｄｉａｔｅｄ　ｃｈｌｏｒｉｄｅ　ｓ' Ｊ　Ｅｔｈｎｏｐｈａｒｍａｃｏｌ Ｖｏｌ．９３，　Ｎｏ．２-３, 2004, ｐｐ．３５１-３５７ *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009535417A (ja) * 2006-05-01 2009-10-01 ナポ ファーマシューティカルズ インク． 下痢型過敏性腸症候群の治療方法
US9980938B2 (en) 2006-05-01 2018-05-29 Napo Pharmaceuticals, Inc. Method for treatment of diarrhea-predominant irritable bowel syndrome
JP2010154769A (ja) * 2008-12-26 2010-07-15 Asahi Breweries Ltd ポリフェノール含有顆粒またはポリフェノール含有チュアブル錠剤およびその製造方法
JP2013540826A (ja) * 2010-10-31 2013-11-07 サリックス ファーマシューティカルズ リミテッド Ｈｉｖ関連の下痢を治療するための方法および組成物
JP2017019806A (ja) * 2010-10-31 2017-01-26 ナポ ファーマシューティカルズ インコーポレイテッド Ｈｉｖ関連の下痢を治療するための方法および組成物

Also Published As

Publication number Publication date
US20120128797A1 (en) 2012-05-24
EP2015639A4 (en) 2009-11-25
CA2650022A1 (en) 2007-11-15
RS52678B (sr) 2013-06-28
WO2007130892A3 (en) 2008-10-30
US20090238901A1 (en) 2009-09-24
JP2014058548A (ja) 2014-04-03
SG195538A1 (en) 2013-12-30
SI2241318T1 (sl) 2013-04-30
CY1113723T1 (el) 2016-06-22
ES2401366T3 (es) 2013-04-19
CA2650022C (en) 2017-05-16
AU2007248182A1 (en) 2007-11-15
KR20090009292A (ko) 2009-01-22
NZ609280A (en) 2014-09-26
PL2241318T3 (pl) 2013-05-31
HRP20130203T1 (hr) 2013-04-30
WO2007130892A2 (en) 2007-11-15
SG161259A1 (en) 2010-05-27
US9138450B2 (en) 2015-09-22
DK2241318T3 (da) 2013-01-21
PT2241318E (pt) 2013-03-18
HK1143541A1 (en) 2011-01-07
EP2241318B1 (en) 2012-12-19
EP2015639A2 (en) 2009-01-21
KR20130067317A (ko) 2013-06-21
AU2007248182B2 (en) 2013-05-23
US8067041B2 (en) 2011-11-29
NZ572049A (en) 2012-08-31
US7556831B2 (en) 2009-07-07
MX2008013768A (es) 2009-02-03
NZ595679A (en) 2013-04-26
EP2241318A1 (en) 2010-10-20
US20080031983A1 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
US8067041B2 (en) Method for treatment of constipation-predominant irritable bowel syndrome
JP5384329B2 (ja) 下痢型過敏性腸症候群の治療方法
AU2013205344B2 (en) Method for treatment of diarrhea-predominant irritable bowel syndrome
AU2013203794A1 (en) Method for treatment of constipation-predominant irritable bowel syndrome
HK1143541B (en) Method for treatment of constipation-predominant irritable bowel syndrome
HK1128861B (en) Method for treatment of diarrhea-predominant irritable bowel syndrome
HK1128861A (en) Method for treatment of diarrhea-predominant irritable bowel syndrome

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100420

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100420

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120816

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121116

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130729